Alloy offers a menopause consultation through an assessment and secure physician messaging. For someone who has questions but has not decided on treatment, that is a different proposition from choosing a product first. The useful test of the process is whether the exchange explains the concern and the proposed next step, rather than simply how quickly a prescription could be shipped.
We reviewed Alloy’s current consultation, HRT and terms pages on September 28, 2026. No assessment, messaging exchange or purchase was tested. This review separates the public invitation to talk from the commercial and clinical conditions that apply if the person continues into treatment. Updated November 9, 2026 using the linked November 8 captures; earlier source dates remain listed.
An assessment should contain the unresolved question
The consultation page advertises a $49 consultation, a short assessment and assignment to a menopause-trained doctor for portal messaging. It says the doctor reviews the assessment and answers questions. The advertised completion time for the form does not establish how long the clinical exchange will take or whether more information will be required.
Our hot-flash and sleep goals guide can help identify what the reader wants clarified before any proposal is accepted. The Winona review discusses another intake-led service where explicitly asking a question matters. A concise form can begin an assessment; it cannot guarantee that the first account contains everything clinically relevant.
Messaging is a format, not immediate availability
Alloy describes chat through its secure portal rather than promising a live video appointment on the consultation page. Its HRT page promotes connection in as little as twelve hours. We treat that as a marketing timeframe, not a response deadline, reserved appointment or verified outcome for a particular account.
For comparison, Wisp’s menopause consult also separates access from a guaranteed live appointment format. A reader can ask whether a longer discussion is possible and how a concern is escalated when messaging is insufficient. The ability to send a message at any hour does not make either service a source of emergency care or continuous real-time clinical attention.
The consultation and the medicines are different purchases
The Alloy HRT page was rechecked October 13, 2026. It still lists a one-time $49 consultation, but the patch now displays $100 per month rather than the $74.99 recorded in our earlier review. The pill starts at $39.99 monthly, with gel and spray shown at $69.99. Each number refers to an offer for a particular form, not one complete menopause-care package.
The patch product page agrees on $100 and describes three-month supplies. The November capture specifies $100 per one-month supply, billed and shipped every three months; it does not identify patch count, strength or manufacturer. Before agreeing to an order, ask how much will be collected, how many patches will arrive and when the next charge occurs. If the clinician proposes progesterone or another medicine, have its cost and purpose explained separately. The right question is the total for the treatment being recommended after assessment, rather than the lowest visible amount. This review has not verified a purchase, discount or response to treatment, and a public form menu does not determine which option is suitable.
A proposed hormone needs a purpose the reader understands
Alloy’s HRT record lists several estradiol forms and says progesterone may be included according to health history. The list does not authorize a person to select, combine or switch medicines independently. Our vaginal-symptom conversation guide helps keep a particular concern distinct from a general request for systemic hormone treatment.
The later-start guide adds questions about timing and earlier decisions. FDA information emphasizes the personal benefits and risks of hormone therapy. Alloy’s percentages and rapid-relief advertising are not evidence of what a particular reader will experience, and we did not use them to rank the quality of its clinicians.
ACOG distinguishes systemic estrogen for hot flashes from local vaginal options for vaginal symptoms. Uterus status shapes whether progestogen is discussed. NICE treats low sexual desire separately; it does not establish a universal libido indication for estrogen. These are general guidance, not measured Alloy outcomes.
The prescribing professional is separate from the platform
Alloy’s terms, revised October 19, 2026, distinguish the company from independent US medical practitioners. They say the service does not replace relationships with regular healthcare professionals and is not for emergencies or urgent situations. A consultation through the website therefore should not be treated as a complete substitute for other care.
The same terms make prescription access conditional on the provider’s decision and restrict service to locations where it is available in the United States. They allow a request to transfer an issued prescription to a pharmacy of choice. That is a published policy, not proof of pharmacy stock, individual eligibility or a successfully completed transfer.
Read cancellation and refund rules as separate clocks
The terms say subscription cancellation must occur seven days before the subscription period ends. They separately require product shipment cancellation or pause requests five business days before processing. Those deadlines concern different events and should not be collapsed into a single casual cancel-anytime description. We have not tested either request process.
Consultation, membership and other service fees are described as nonrefundable. Physical-product refund requests are limited to the first shipment of each product and must be made within thirty days of receipt, with other exclusions and conditions. These rules do not promise that a consultation fee is returned if the resulting treatment suggestion is not what the person hoped to receive.
Replacement requests for damage or loss have a separate 14-day window, measured from actual or expected delivery respectively. The conditions require verification and offer replacement, without a refund.
Continuing access should keep the clinical issue visible
The consultation page makes unlimited physician messaging conditional on purchasing a prescription. That is important for someone who only wants the initial conversation: ongoing access should not be assumed without confirming its conditions. The terms also allow messaging access to be suspended when subscription payment is not current.
Our bleeding-history guide illustrates why a new clinical concern cannot be reduced to account administration. The patient needs to know which professional remains responsible and how to obtain appropriate care when the portal cannot resolve an issue. Alloy’s public records describe a pathway for discussion and conditional prescribing; they do not establish an individual clinical outcome or a guaranteed uninterrupted care relationship.
The patch offer links messaging to an active prescription and shipping to prescription approval. Failed payments can hold shipments as well as restrict messaging.
A billing problem needs an administrative answer and a separate conversation with the treating clinician about continuity. Account status is not an instruction to change a medicine.
Read alongside the article
Sources & notes.
These sources provide provider descriptions or medical context. They do not replace an individual clinical assessment.
- Alloy consultation: assessment, portal physician messaging and fee ↗Official consultation page; advertised format and price, no encounter or checkout tested · Checked 2026-09-28
- Alloy hormone replacement therapy options and treatment-price displays ↗Official HRT service page; thirty-day treatment price units and one-time consultation fee, no selected order verified · Checked 2026-10-13
- FDA: Menopause ↗Current federal patient guidance; individualized benefits/risks and prevention limits, no class-wide labeling-change inference · Checked 2026-09-28
- Alloy terms of use, revised May 28, 2026 ↗Official platform and transaction terms; distinct cancellation and shipment deadlines, conditional refunds and clinical responsibility · Checked 2026-09-28
- Alloy: estradiol patch supply and price ↗Provider published price and shipment description · Checked 2026-10-13
- Alloy: patch offer · November capture ↗Provider record · Checked 2026-11-08
- Alloy: conditions · November capture ↗Provider record · Checked 2026-11-08
- ACOG: hormone guidance · November capture ↗Clinical guidance · Checked 2026-11-08
- NICE: menopause guidance · November capture ↗Clinical guidance · Checked 2026-11-08